A Trial of Tisotumab Vedotin in Cervical Cancer

Condition:   Cervical Cancer Intervention:   Drug: tisotumab vedotin Sponsors:   Genmab;   Seattle Genetics, Inc.;   European Network of Gynaecological Oncological Trial Groups (ENGOT);   Belgian Gynaecological Oncology Group;   Gynecologic Oncology Group Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials